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ABSTRACT 
A  simple,  precise  and  accurate  difference  spectroscopic  method  has been  developed  for  the  estimation  of  prasugrel hydrochloride  in  bulk  and  in  
pharmaceutical  dosage form. The proposed method is based on the principle that prasugrel hydrochloride exhibits in two different  chemical  forms that  
differs  in the  absorption  spectra  in  basic  and  acidic  medium. The absorbances were measured in acidic and basic solution separately against reagent blank. 
Prasugrel hydrochloride  has  exhibited  maximum absorbance at 254 nm and 239 nm in acidic and basic solution respectively. Difference in absorbances 
between these two maxima was calculated to find out the amplitude. The amplitude plotted against concentration, showed linear response in the concentration 
range of 5-30 µg/ml with the linear regression value 0.997. The proposed method was applied to pharmaceutical formulations and the common excipients 
present in the formulation did not interfere in the analysis of the drug. The method was validated as per ICH guidelines and statistical results of analysis were 
found to be satisfactory. 
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INTRODUCTION 
Prasugrel hydrochloride (PRL), 5-[2-cyclopropyl-1-(2-fluoro-
phenyl)-2-oxoethyl]-4,5,6,7-tetra    hydrothieno    [3,2-c]  
pyridin-2-yl  acetate hydrochloride (Figure 1). It is a member 
of  third  generation  thienopyridine  class  of  ADP  receptor 
inhibitors  which  gets  metabolized  to  an  irreversible  P2Y12 
receptor  inhibitor.  It  is  used  as  an  antiplatelet  therapy  in 
patients  with  acute  coronary  syndromes.  Compared  to  the 
standard  therapy  (Clopidogrel,  a  second  generation 
thienopyridine), PRL has a more rapid, predictable and potent 
antiplatelet  effect  with  a  longer  duration  of  platelet 
inhibition.
1-3   
Literature survey reveals that a few analytical methods like 
LC-MS
4,  HPTLC
5  HPLC
6-7  and  some  spectrophotometric 
methods
8-9 have been reported for the estimation of PRL. As 
per our knowledge there was no any difference spectroscopic 
method  was  found  to  be  reported  in  literature.  Hence  the 
main  objective  of  this  study  was  to  develop  a  simple  and 
accurate  method  for  estimation  of  PRL  in  bulk  and  tablet 
dosage form. 
MATERIALS AND METHODS 
Chemicals and reagents 
Prasugrel hydrochloride was obtained as a gift sample. The 
commercially  available  tablet,  “Prasusafe”  5  mg  (MSN 
Laboratories  Ltd.,  Bollaram)  containing 5 mg  of  PRL  was 
procured from the local market and used for analysis. 
Freshly prepared 0.1N sodium hydroxide, 0.1N hydrochloric 
acid and distilled water were used in the present analysis. 
Instruments  
A Jasco V-530 UV-Visible double beam Spectrophotometer 
with 1 cm matched pair quartz cell was used for all spectral 
measurements. The absorption spectrum was recorded in the 
wavelength range of 200-400nm throughout the experimental 
work. 
Difference spectroscopy 
Selectivity  and  accuracy  of  spectrophotometric analysis  of  
sample  containing  absorbing interference may be  markedly  
improved  by  the  technique    like  difference 
spectrophotometry.  The  essential    feature    of    difference  
spectrophotometric assay  is  that  the  measured  value  is  
the difference  in  absorbance (A)  between  two  equimolar  
solutions  of  the  analyte in different chemical forms which 
exhibit  different  spectral  characteristics.  This    is    simplest  
and  most commonly  employed  technique  for  altering  the 
spectral properties  of an analyte by the adjustment of pH by 
means of aqueous solution of acid, alkali or  buffer. 
Preparation of standard stock solution 
Standard stock solution was prepared by dissolving the 10 
mg of PRL in 10 ml methanol. 2.5 ml of resultant solution 
was pipette out and diluted to 25 ml with methanol to get 
final concentration of about 0.1mg/ml.  
Preparation of working standard solution  
Working  standard  solution  was  prepared  by  series  of 
dilutions  of  0.5,  1,  1.5,  2,  2.5 and  3  ml  of  standard  stock 
solution to 10 ml of 0.1N HCl and 0.1N NaOH separately to 
get  concentrations  of  5,  10, 15, 20, 25, 30μg/ml  for PRL. 
These solutions were used to determine absorption maxima, 
beer's law and linearity.  
Determination of λ max 
The  above prepared solutions  were scanned  over  the  range  
of  400  nm  to  200  nm  against reagent blank. From the 
spectrum obtained, the λmax was found to be 254 nm (Figure 
3)  and  239  nm  (Figure  4)  in  acidic  and  basic  solutions 
respectively.  Difference  in  absorbances  between  these  two 
maxima was calculated to find out the amplitude.  
METHOD VALIDATION 
The  method  was  validated  for  different  parameters  like 
linearity,  accuracy  and  precision  according  to  the  ICH 
guidelines
10. 
Linearity  
The linearity of the method is its ability to elicit test results 
that  are  directly  proportional  to  the  concentration  of  the 
analyte  in  the  samples.  From  the  standard  stock  solution, 
series of dilutions were made to 10 ml with 0.1 N HCl and 
0.1 N NaOH separately to get concentrations of 5, 10, 15, 20, 
25, 30μg/ml for PRL. The  absorbances  were  measured  at  
254  nm    and    239  nm    in    acidic    and    basic    solutions 
respectively  against  reagent  blank. Calibration curve was Desai Darshali Satishkumar et al. IRJP 2012, 3 (5) 
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prepared  by  plotting  concentration  versus  difference  in 
absorbance and found to be linear in the concentration range 
of 5-30 µg/ml (Figure 2). 
Precision 
Precision  of  the  method  was  determined  by  performing 
interday variation, intraday variation and repeatability studies 
and expressed in forms of %RSD. In interday variation, the 
absorbances  of  working  standard  solutions  of  PRL  (5-30 
µg/ml) were measured on three consecutive days. In intraday 
variation the absorbances were measured three times a day. 
In  repeatability  study,  six  determinations  of  the  fixed 
concentration of both acidic and basic solutions of the drug 
were analyzed separately. The results of precision data are 
given in Table 2.  
LOD and LOQ 
In  this  study,  LOD  and  LOQ  were  based  on  the  standard 
deviation  of  the  response  (σ)  and  the  slope  of  the 
corresponding curve (S) using the following equation: 
LOD = 3.3σ/S,   LOQ = 10σ/S 
Where,  σ is the standard deviation of the response of blank, 
S is the slope of calibration curve. 
The results of validation parameters are shown in Table 1. 
Analysis of tablet formulation 
Twenty  tablets  were  accurately  weighed  and  triturate 
thoroughly to get fine powder. The powder equivalent to 25 
mg  of  PRL  was  weighed  and  transferred  into  25  ml 
volumetric flask. The contents of the flask were dissolved in 
the 10 ml of the methanol with the aid of ultrasonication for 
10 mins. The solution was filtered through whatmann filter 
paper  no.  41  and  volume  was  made  up  to  25  ml  with 
methanol. From the resultant solution, further dilutions were 
prepared with 0.1 N HCl and 0.1 N NaOH separately to get 
final concentration of PRL. The absorbances were measured 
at selected wavelengths and the concentration of each analyte 
was determined with the equation obtained from calibration 
curve. 
Accuracy (Recovery studies) 
The  accuracy  of  the  proposed  method  was  determined  by 
calculating the recoveries  of PRL  by the standard addition 
method. It was determined by preparing solutions of different 
concentrations at 80%, 100% and 120% in which the amount 
of marketed formulation was kept constant (10 µg/ml) and 
the amount of pure drug was varied that is 2 µg/ml, 5 µg/ml 
and  8  µg/ml  for  80%,  100%  and  120%  respectively.  The 
amount  of  PRL  recovered  was  estimated  by  applying 
obtained values to the regression line equation. The results of 
% recovery are given in Table 3. 
RESULTS AND DISCUSSION  
Prasugrel HCl obeys Beer’s law in the concentration range of 
5-30µg/ml  with  the  linear  regression  value  0.997.  The  % 
RSD for intraday, interday precision and repeatability study, 
less  than  2%  and  recovery  study  with  SD  less  than  2%, 
indicates that the method is precise and accurate. Further it 
was  concluded  that,  there  was  no  any  interference  of 
excipients in analysis of marketed formulation. Therefore the 
present  method  can  be  employed  for  the  estimation  of 
prasugrel in pharmaceutical formulations.  
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TABLE 1: Validation parameters of prasugrel HCl 
Parameters  Prasugrel hydrochloride 
λmax (nm)  254nm (0.1 N HCl) 
239nm  (0.1N NaOH) 
Linearity range  5-30µg/ml 
Correlation coefficient  0.997 
Regression equation (Y = mx + c)  y = 0.007x - 0.029 
Slope (m)  0.007 
Intercept (c)  0.029 
LOD  0.676µg/ml 
LOQ  2.02µg/ml 
 
TABLE 2: Precision data 
  Fortified 
amount 
(mg) 
Amount 
found 
(mg) 
% RSD 
Intraday 
(n = 3) 
10  9.96  0.64 
15  14.89  0.54 
25  24.90  1.09 
Interday 
(n = 3) 
10  9.87  0.79 
15  14.93  0.68 
25  24.82  0.53 
Repeatability  (n = 
6)  15  14.87  0.73 
 
 
TABLE 3: Results of % recovery in tablet formulation 
Formulation 
 
Estimation of prasugrel in tablet 
formulation 
%Recovery of prasugrel 
Tab. Prasusafe 
Label 
claim 
(mg) 
Amount 
found 
(mg) 
% RSD  % of 
drug 
added 
Concentration 
(µg/ml) 
% of drug 
recovered 
% RSD 
Pure drug  Formulation 
5  4.91 
0.6 
80%  2  10  97.5  0.87 
5  4.89  100%  5  10  100.4  0.62 
5  4.85  120%  8  10  104.25  0.43 Desai Darshali Satishkumar et al. IRJP 2012, 3 (5) 
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Figure 1: Chemical structure of prasugrel hydrochloride 
 
 
Figure 2: Calibration curve of prasugrel hydrochloride 
 
 
Figure 3: Overlay spectra of PRL with 0.1N HCl at 254nm                
 
 
Figure 4: Overlay spectra of PRL with 0.1N NaOH at 239nm 
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